(Q43638397)

25 November 2017

title

Mutant mice lacking the cholecystokinin2 receptor show a dopamine-dependent hyperactivity and a behavioral sensitization to morphine (English)

1 reference

25 November 2017

Daugé V

1

1 reference

25 November 2017

Beslot F

series ordinal

2

1 reference

25 November 2017

Matsui T

series ordinal

3

1 reference

25 November 2017

Roques BP

series ordinal

4

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 June 2001

1 reference

25 November 2017

number of pages

4

1 reference

inferred from page(s)

published in

Neuroscience Letters

1 reference

25 November 2017

volume

306

1 reference

25 November 2017

issue

1-2

1 reference

25 November 2017

page(s)

41-44

1 reference

Anxiolytic effects of CCK-B antagonists

25 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Biological actions of cholecystokinin

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Effect of inhibiting enkephalin catabolism in the VTA on motor activity and extracellular dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

CCK in anxiety and cognitive processes.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Evidence for coexistence of dopamine and CCK in meso-limbic neurones

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Neurotransmitter regulation of dopamine neurons in the ventral tegmental area

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Dopamine transmission in the initiation and expression of drug- and stress-induced sensitization of motor activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

The CCK-B agonist, BC264, increases dopamine in the nucleus accumbens and facilitates motivation and attention after intraperitoneal injection in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

G protein-coupled cholecystokinin-B/gastrin receptors are responsible for physiological cell growth of the stomach mucosa in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

CCK-B receptor: chemistry, molecular biology, biochemistry and pharmacology

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Autoradiography of CCK receptors in the rat brain using [(3)H]Boc[Nle(28)(31)]CCK(27)-(33) and [(125)I]bolton-hunter CCK(8). Functional significance of subregional distributions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Cholecystokinin (CCK) and schizophrenia: the selective CCKB antagonist LY262691 decreases midbrain dopamine unit activity

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Dual ultrastructural localization of enkephalin and tyrosine hydroxylase immunoreactivity in the rat ventral tegmental area: multiple substrates for opiate-dopamine interactions.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

Cholecystokinin and psychiatric disorders : role in aetiology and potential of receptor antagonists in therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2801%2901867-5

7 January 2021

10.1016/S0304-3940(01)01867-5

Identifiers

DOI

1 reference

25 November 2017

1 reference